Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 1.00 |
| ▸ | GABRG2 | P18507 | 1/20 | 1.00 |
| ▸ | GABRB3 | P28472 | 1/20 | 1.00 |
| ▸ | GABRA3 | P34903 | 1/20 | 1.00 |
| ▸ | GABRA2 | P47869 | 1/20 | 1.00 |
| ▸ | GABRB2 | P47870 | 1/20 | 1.00 |
| ▸ | CALM1 | P0DP23 | 6/20 | 0.70 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.65 |
| ▸ | NOS2 | P35228 | 1/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Batatasin Iii SCHEMBL11505373 | 1.00 | GABRA1 (1.00) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| Batatasin Iii SCHEMBL29352616 | 1.00 | GABRA1 (1.00) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL20179598 | 0.95 | GABRA1 (0.90) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL30574244 | 0.93 | GABRA1 (0.87) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL27968568 | 0.89 | GABRA1 (0.81) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL11504762 | 0.88 | GABRA1 (0.78) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL27968433 | 0.84 | GABRA1 (0.73) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL16568144 | 0.82 | CALM1 (0.86) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL29862145 | 0.82 | CALM1 (0.86) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL27254011 | 0.82 | CALM1 (1.00) | GABRA1GABRG2GABRB3GABRA3GABRA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026314-A1 | POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS | ROTHSTEIN STEVEN (CA) | 2024-01-25 | — | — | US | claimed |
| EP-4251758-A1 | POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS | Rothstein, Steven (CA) | 2023-10-04 | — | — | EP | claimed |
| WO-2023150534-A1 | SMALL MOLECULE PIM AND MTOR KINASE INHIBITOR AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2023-08-10 | — | — | WO | claimed |
| CN-114586627-B | Planting method for promoting growth of cymbidium sinense and accumulation of active ingredients | 中国科学院昆明植物研究所 | 2023-08-01 | — | — | CN | claimed |
| CN-114586627-A | Planting method for promoting growth and effective component accumulation of Pleione | 中国科学院昆明植物研究所 | 2022-06-07 | — | — | CN | claimed |
| WO-2022109736-A1 | POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS | ROTHSTEIN STEVEN (CA) | 2022-06-02 | — | — | WO | claimed |
| US-20250129045-A1 | SMALL MOLECULE PIM AND MTOR KINASE INHIBITOR AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2025-04-24 | — | — | US | disclosed |
| EP-4496567-A1 | USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS | Chang Gung University (TW) | 2025-01-29 | — | — | EP | disclosed |
| US-20240269220-A1 | USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS | CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) | 2024-08-15 | — | — | US | disclosed |
| US-20240026314-A1 | POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS | ROTHSTEIN STEVEN (CA) | 2024-01-25 | — | — | US | disclosed |
| EP-4251758-A1 | POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS | Rothstein, Steven (CA) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023178592-A1 | USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS | CHANG GUNG UNIVERSITY (CN) | 2023-09-28 | — | — | WO | disclosed |
| WO-2023150534-A1 | SMALL MOLECULE PIM AND MTOR KINASE INHIBITOR AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2023-08-10 | — | — | WO | disclosed |
| CN-114586627-B | Planting method for promoting growth of cymbidium sinense and accumulation of active ingredients | 中国科学院昆明植物研究所 | 2023-08-01 | — | — | CN | disclosed |
| CN-114586627-B | Planting method for promoting growth of cymbidium sinense and accumulation of active ingredients | 中国科学院昆明植物研究所 | 2023-08-01 | — | — | CN | disclosed |
| CN-115845065-A | Use of FN/FAK pathway inhibitor in preparation of medicine for improving thyroid cancer radioiodine treatment sensitivity | 江苏省原子医学研究所 | 2023-03-28 | — | — | CN | disclosed |
| CN-114586627-A | Planting method for promoting growth and effective component accumulation of Pleione | 中国科学院昆明植物研究所 | 2022-06-07 | — | — | CN | disclosed |
| CN-114586627-A | Planting method for promoting growth and effective component accumulation of Pleione | 中国科学院昆明植物研究所 | 2022-06-07 | — | — | CN | disclosed |
| WO-2022109736-A1 | POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS | ROTHSTEIN STEVEN (CA) | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129045-A1 | SMALL MOLECULE PIM AND MTOR KINASE INHIBITOR AND METHODS OF USE THEREOF | PIM3, PIM1, PIM2 | GABRA1 3988/4885GABRG2 3678/4885GABRB3 2631/4885 |
| US-20240026314-A1 | POLYPEPTIDES FOR USE IN THE SYNTHESIS OF BIOACTIVE PHENOLIC COMPOUNDS | COMT, PNMT, GNMT | GABRA1 4540/4885GABRG2 4454/4885GABRB3 4123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.